Anthony MR et al
KLOW components provide critical support
IGF-1R activation initiates PI3K/Akt/mTOR and MAPK/ERK cascades implicated in anabolic processes, making IGF-1 axis compounds valuable tools for investigating growth factor biology in controlled experimental systems
The result is characteristic: sudden, painless, sometimes heavy loss of dark red or maroon blood
As a triple incretin receptor agonist, it: Activates GLP-1 receptors , reducing appetite, slowing gastric emptying, and improving insulin secretion Activates GIP receptors , enhancing insulin response and potentially supporting fat metabolism Activates glucagon receptors , increasing energy expenditure and hepatic glucose output Whilst glucagon receptor activation increases hepatic glucose output, the net glycaemic effect of retatrutide is mitigated by the concurrent GLP-1 and GIP activity, resulting in overall improvements in glycaemic control in trial participants
Medical research: if depression were cancer